Classification and basic properties of contrast agents for magnetic resonance imaging

被引:428
作者
Geraldes, Carlos F. G. C. [1 ,2 ]
Laurent, Sophie [3 ]
机构
[1] Univ Coimbra, Dept Biochem, Fac Sci & Technol, P-3001401 Coimbra, Portugal
[2] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3001401 Coimbra, Portugal
[3] Univ Mons, NMR & Mol Imaging Lab, Dept Gen Organ & Biomed Chem, B-7000 Mons, Belgium
关键词
lanthanide complexes; contrast agents; magnetic resonance imaging; SUPERPARAMAGNETIC IRON-OXIDE; SATURATION-TRANSFER AGENTS; PROTON CHEMICAL-EXCHANGE; 1ST HUMAN-EXPERIENCE; MRI-CONTRAST; IN-VIVO; HIGH-RELAXIVITY; GADOLINIUM(III) COMPLEXES; RELAXATION ENHANCEMENT; PARAMAGNETIC LIPOSOMES;
D O I
10.1002/cmmi.265
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A comprehensive classification of contrast agents currently used or under development for magnetic resonance imaging (MRI) is presented. Agents based on small chelates, macromolecular systems, iron oxides and other nanosystems, as well as responsive, chemical exchange saturation transfer (CEST) and hyperpolarization agents are covered in order to discuss the various possibilities of using MRI as a molecular imaging technique. The classification includes composition, magnetic properties, biodistribution and imaging applications. Chemical compositions of various classes of MRI contrast agents are tabulated, and their magnetic status including diamagnetic, paramagnetic and superparamagnetic are outlined. Classification according to biodistribution covers all types of MRI contrast agents including, among others, extracellular, blood pool, polymeric, particulate, responsive, oral, and organ specific (hepatobiliary, RES, lymph nodes, bone marrow and brain). Various targeting strategies of molecular, macromolecular and particulate carriers are also illustrated. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:1 / 23
页数:23
相关论文
共 171 条
[111]   DTPA-bisamide-based MR sensor agents for peroxidase imaging [J].
Querol, M ;
Chen, JW ;
Weissleder, R ;
Bogdanov, A .
ORGANIC LETTERS, 2005, 7 (09) :1719-1722
[112]   Renal and systemic pH imaging by contrast-enhanced MRI [J].
Raghunand, N ;
Howison, C ;
Sherry, AD ;
Zhang, SR ;
Gillies, RJ .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (02) :249-257
[113]   CLINICAL-RESULTS WITH RESOVIST - A PHASE-2 CLINICAL-TRIAL [J].
REIMER, P ;
RUMMENY, EJ ;
DALDRUP, HE ;
BALZER, T ;
TOMBACH, B ;
BERNS, T ;
PETERS, PE .
RADIOLOGY, 1995, 195 (02) :489-496
[114]   T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: Dependence on field strength and plasma concentration preliminary clinical experience with dynamic T1-weighted MR imaging [J].
Reimer, P ;
Muller, M ;
Marx, C ;
Wiedermann, D ;
Muller, R ;
Rummeny, EJ ;
Ebert, W ;
Shamsi, K ;
Peters, PE .
RADIOLOGY, 1998, 209 (03) :831-836
[115]   ORAL MAGNETIC PARTICLES IN MR IMAGING OF THE ABDOMEN AND PELVIS [J].
RINCK, PA ;
SMEVIK, O ;
NILSEN, G ;
KLEPP, O ;
ONSRUD, M ;
OKSENDAL, A ;
BORSETH, A .
RADIOLOGY, 1991, 178 (03) :775-779
[116]   Theory of proton relaxation induced by superparamagnetic particles [J].
Roch, A ;
Muller, RN ;
Gillis, P .
JOURNAL OF CHEMICAL PHYSICS, 1999, 110 (11) :5403-5411
[117]   Nephrogenic systemic fibrosis: A chemical perspective [J].
Rofsky, Neil M. ;
Sherry, A. Dean ;
Lenkinski, Robert E. .
RADIOLOGY, 2008, 247 (03) :608-612
[118]   Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths [J].
Rohrer, M ;
Bauer, H ;
Mintorovitch, J ;
Requardt, M ;
Weinmann, HJ .
INVESTIGATIVE RADIOLOGY, 2005, 40 (11) :715-724
[119]   A multicenter clinical trial of Gadolite Oral Suspension as a contrast agent for MRI [J].
Rubin, DL ;
Falk, KL ;
Sperling, MJ ;
Ross, M ;
Saini, S ;
Rothman, B ;
Shellock, F ;
Zerhouni, E ;
Stark, D ;
Outwater, EK ;
Schmiedl, U ;
Kirby, LC ;
Chezmar, J ;
Coates, T ;
Chang, M ;
Silverman, JM ;
Rofsky, N ;
Burnett, K ;
Engel, J ;
Young, SW .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (05) :865-872
[120]  
Saeed M, 2000, J MAGN RESON IMAGING, V12, P890